Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyethyl Starch and Hydrocortisone in Acute Aluminum Phosphide Poisoning
NCT04465539Completed
- Sponsor
- Tanta University
- Start
- Jul 2020
- Primary completion
- Feb 2024
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Volulyte and hydrocortisone in aluminum phosphide poisoning, sponsored by Tanta University. Primary endpoint: Mortality at 28 days. Started Jul 2020; status: completed.
02
Drugs
Volulytehydrocortisone
03
Conditions
aluminum phosphide poisoning
Beyond the preview
Go deeper on NCT04465539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04465539.